We are preparing the requested document. Please wait, this may take a while...!
|Application / Reactivity||Dog (Canine)|
|Flow Cytometry (FACS)||10 Antibodies|
|Western Blotting (WB)||2 Antibodies|
|Antigen||Interleukin 2 Receptor, alpha (IL2RA) Antibodies|
|Reactivity||Dog (Canine) Alternatives|
|Conjugate||This CD25 antibody is conjugated to PE Alternatives|
Flow Cytometry (FACS)
|4 references available|
|Supplier||Log in to see|
Product Details anti-CD25 AntibodyTarget Details CD25 Application Details Handling References for anti-CD25 Antibody (ABIN2479448) Images
Target Details CD25Product Details anti-CD25 Antibody Application Details Handling References for anti-CD25 Antibody (ABIN2479448) Images back to top
|Alternative Name||CD25 (IL2RA Antibody Abstract)|
|Research Area||CD Antigens, Surface Receptors of Immune Cells|
Application DetailsProduct Details anti-CD25 Antibody Target Details CD25 Handling References for anti-CD25 Antibody (ABIN2479448) Images back to top
|Application Notes||Optimal working dilution should be determined by the investigator.|
|Restrictions||For Research Use only|
References for anti-CD25 Antibody (ABIN2479448)Product Details anti-CD25 Antibody Target Details CD25 Application Details Handling Images back to top
|Product cited in:||
Finn, Ozelo, Sabatino et al.: "Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy." in: Blood, Vol. 116, Issue 26, pp. 5842-8, 2010 (PubMed).
Rissetto, Rindt, Selting et al.: "Cloning and expression of canine CD25 for validation of an anti-human CD25 antibody to compare T regulatory lymphocytes in healthy dogs and dogs with osteosarcoma." in: Veterinary immunology and immunopathology, Vol. 135, Issue 1-2, pp. 137-45, 2010 (PubMed).
Abrams, Hwang, Lesnikova et al.: "A novel monoclonal antibody specific for canine CD25 (P4A10): selection and evaluation of canine Tregs." in: Veterinary immunology and immunopathology, Vol. 135, Issue 3-4, pp. 257-65, 2010 (PubMed).
McLaren, Pontiggia: "The basis for hyperthermia becoming the fourth cancer treatment modality in the 1990's." in: Advances in experimental medicine and biology, Vol. 267, pp. 21-36, 1991 (PubMed).
ImagesProduct Details anti-CD25 Antibody Target Details CD25 Application Details Handling References for anti-CD25 Antibody (ABIN2479448) back to top